The rapidly changing treatment landscape of first-line advanced urothelial cancer (aUC) or metastatic urothelial cancer (mUC)

The landscape of treatment for first-line therapy in advanced urothelial cancer (aUC) and metastatic urothelial cancer (mUC) has rapidly changed in the last year alone. Maintenance avelumab remains a viable treatment option for many patients across the globe for those who have responded or have achi...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Minira Aslanova, Eun-Mi Yu, Jeanny B. Aragon-Ching
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Open Exploration Publishing Inc. 2024-07-01
Schriftenreihe:	Exploration of Targeted Anti-tumor Therapy
Schlagworte:	cisplatin-eligible avelumab maintenance enfortumab vedotin pembrolizumab nivolumab
Online-Zugang:	https://www.explorationpub.com/Journals/etat/Article/1002258
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!